| Product Code: ETC6189745 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s rat model market is expanding with the increasing demand for preclinical studies in drug development and genetic research. The use of rat models in neurological, cardiovascular, and cancer research remains prevalent. Academic institutions and contract research organizations (CROs) are the primary users, and government policies support ethical animal use through stringent guidelines and funding for alternative models.
The rat model market in Australia is expanding, driven by increased demand for preclinical research in pharmaceuticals, toxicology, and genetics. Researchers prefer rat models due to their physiological similarities to humans and suitability for disease modeling. The rise of biotechnology firms and academic research institutes is contributing to higher adoption rates, alongside improvements in genetically engineered rat models.
The Australia Rat Model Market faces challenges in ensuring ethical compliance and managing increasing regulatory scrutiny around animal testing. There is growing pressure to develop alternative methods, such as in vitro and in silico models, which may reduce demand for traditional rat models. Additionally, high maintenance and breeding costs, along with the need for genetically modified models, increase operational complexity and expenses.
The rat model market in Australia offers promising investment prospects due to its pivotal role in preclinical research and drug development. Academic and private sector research institutions continue to require high-quality genetically modified rat models for studying complex diseases. The market is supported by Australia`s strong ethical frameworks and advanced laboratory facilities, providing a stable environment for contract research organizations (CROs) and biopharma companies to expand their animal model operations.
Animal research regulations in Australia are guided by the Australian Code for the Care and Use of Animals for Scientific Purposes, which governs the ethical treatment of laboratory animals, including rats. State-level animal ethics committees oversee research projects, and policies require stringent welfare protocols, licensing, and justification for using animal models. The government also funds alternatives to animal testing under its biomedical innovation agenda, potentially influencing the demand and usage of rat models in the long run.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Rat Model Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Rat Model Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Rat Model Market - Industry Life Cycle |
3.4 Australia Rat Model Market - Porter's Five Forces |
3.5 Australia Rat Model Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Rat Model Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Australia Rat Model Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Australia Rat Model Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Australia Rat Model Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Australia Rat Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the pharmaceutical and biotechnology industries in Australia |
4.2.2 Growing demand for personalized medicine and precision healthcare solutions |
4.2.3 Rise in investments in the healthcare sector for drug discovery and development |
4.3 Market Restraints |
4.3.1 Stringent regulations and ethical considerations related to the use of animal models in research |
4.3.2 High costs associated with the maintenance and care of rat models |
4.3.3 Limited availability of specific strains or genetically modified rat models |
5 Australia Rat Model Market Trends |
6 Australia Rat Model Market, By Types |
6.1 Australia Rat Model Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Rat Model Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Rat Model Market Revenues & Volume, By Knockout, 2021- 2031F |
6.1.4 Australia Rat Model Market Revenues & Volume, By Outbred, 2021- 2031F |
6.1.5 Australia Rat Model Market Revenues & Volume, By Inbred, 2021- 2031F |
6.1.6 Australia Rat Model Market Revenues & Volume, By Hybrid, 2021- 2031F |
6.1.7 Australia Rat Model Market Revenues & Volume, By Immunodeficient, 2021- 2031F |
6.1.8 Australia Rat Model Market Revenues & Volume, By Conditioned, 2021- 2031F |
6.2 Australia Rat Model Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Australia Rat Model Market Revenues & Volume, By Nuclear Transferase, 2021- 2031F |
6.2.3 Australia Rat Model Market Revenues & Volume, By Microinjection, 2021- 2031F |
6.2.4 Australia Rat Model Market Revenues & Volume, By Embryonic Stem Cell, 2021- 2031F |
6.2.5 Australia Rat Model Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Rat Model Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Australia Rat Model Market Revenues & Volume, By Cryopreservation, 2021- 2031F |
6.3.3 Australia Rat Model Market Revenues & Volume, By Breeding, 2021- 2031F |
6.3.4 Australia Rat Model Market Revenues & Volume, By Re-derivation, 2021- 2031F |
6.3.5 Australia Rat Model Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.3.6 Australia Rat Model Market Revenues & Volume, By Quarantine Depending, 2021- 2031F |
6.3.7 Australia Rat Model Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Australia Rat Model Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Australia Rat Model Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.3 Australia Rat Model Market Revenues & Volume, By Neurology, 2021- 2031F |
6.4.4 Australia Rat Model Market Revenues & Volume, By Immunology, 2021- 2031F |
6.4.5 Australia Rat Model Market Revenues & Volume, By Toxicology, 2021- 2031F |
6.4.6 Australia Rat Model Market Revenues & Volume, By Other, 2021- 2031F |
6.5 Australia Rat Model Market, By End use |
6.5.1 Overview and Analysis |
6.5.2 Australia Rat Model Market Revenues & Volume, By CROs, 2021- 2031F |
6.5.3 Australia Rat Model Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.5.4 Australia Rat Model Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
7 Australia Rat Model Market Import-Export Trade Statistics |
7.1 Australia Rat Model Market Export to Major Countries |
7.2 Australia Rat Model Market Imports from Major Countries |
8 Australia Rat Model Market Key Performance Indicators |
8.1 Number of research grants awarded for projects involving rat models |
8.2 Adoption rate of rat models in preclinical studies by pharmaceutical companies |
8.3 Number of new drug discoveries or breakthroughs attributed to research using rat models |
9 Australia Rat Model Market - Opportunity Assessment |
9.1 Australia Rat Model Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Rat Model Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Australia Rat Model Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Australia Rat Model Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Australia Rat Model Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Australia Rat Model Market - Competitive Landscape |
10.1 Australia Rat Model Market Revenue Share, By Companies, 2024 |
10.2 Australia Rat Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here